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Unilateral nevoid telangiectasia syndrome (UNTS) 
is a rare disease characterized by superficial telangi-
ectasias in a dermatomal distribution. It is generally 
unilateral and frequently distributed in the C3-C4 or 
trigeminal nerve dermatomes (1). There are various 
opinions on the pathogenesis, which can be con-
genital or acquired. Here, we intended to make a new 
contribution to the pathogenesis of the disease by 
presenting a male patient with UNTS accompanied 
by chronic hepatitis B virus infection.
An 18-year-old male patient presented to our out-
patient clinic with asymptomatic telangiectasias that 
appeared 3 years previously and increased gradually. 
He had no systemic diseases or history of alcohol con-
sumption. Physical examination was normal. Derma-
tologic examination revealed a few fine, branching 
unilateral telangiectasias located on the left half of 
the upper lip, left upper and lower eyelids, and left 
side of the neck, which were in accordance with the 
C3 dermatome, ophthalmic and maxillary branches 
of the trigeminal nerve (Fig. 1a, b). Complete blood 
count, erythrocyte sedimentation rate, urine analy-
sis, renal and hepatic parameters, thyroid function 
tests, bleeding and coagulation parameters, blood 
estrogen level, anti-nuclear antibody and thyroid 
autoantibodies, and HIV serology were within the 
normal range. Hepatitis B surface antigen (HBsAg), 
HBVe antibodies and HBV-DNA were positive, which 
led to the diagnosis of chronic hepatitis B. There was 
no evidence of liver cirrhosis. Punch biopsy of the le-
sional skin revealed fine, dilated vessels located in the 
middle and upper dermis (Fig. 2). Immune reactivity 
was negative for estrogen and progesterone recep-
tors. Taking into consideration the distribution of the 
lesions, histopathology and laboratory test results, 
the patient was diagnosed as UNTS accompanied by 
chronic hepatitis B.  
UNTS is thought to be associated with physiologi-
cal and pathological hyperestrogenemic states such 
as pregnancy, puberty, hepatic disease, and hormon-
al therapy. However, Wenson et al. (1) showed that 
hormonal theory was not valid for all cases and there 
Figure 1a, b. Telangiectasias located on the upper lip, left upper and lower eyelids, and left side of the neck.
136 ACTA DERMATOVENEROLOGICA CROATICA
were cases with no underlying disease or hormonal 
abnormality. Even though our patient had accompa-
nying hepatitis B infection, there was no concomitant 
hormonal pathology. There are a few UNTS cases as-
sociated with hepatitis B or C infection in the litera-
ture. Almazan Fernandez et al. (2) report on a male 
patient with UNTS and chronic hepatitis B in non-rep-
licative phase without a sign of cirrhosis. Karakas et al. 
(3) report on a female hepatitis B carrier with UNTS. 
Hynes and Shenefelt (4) report on two male UNTS 
patients with hepatitis C without a sign of cirrhosis. 
In all three reports, serum estrogen levels and tissue 
estrogen/progesterone receptor levels were normal. 
These authors agree that the somatic mosaicism is 
the cause of UNTS and vague telangiectasias become 
visible when estrogen levels increase, either physi-
ologically or pathologically. Different from these case 
reports, our case had a detectable viral load and he 
was a chronic hepatitis B patient, not a carrier. Even 
though the effect of estrogen has been referred to in 
those reports, neither those patients nor our patient 
had elevated estrogen levels. Therefore, a clear rela-
tion between UNTS and hepatitis without a sign of 
cirrhosis could not be established. 
Vascular endothelial growth factor (VEGF) is a pro-
tein that plays a critical role in vascular development 
and new vessel formation. In a study on serum VEGF 
levels in various hepatic diseases, the authors reported 
that acute hepatocellular damage caused significant 
amounts of VEGF to be released into the circulation 
(5). In a similar study, Makhlouf et al. (6) report that 
VEGF levels were higher in patients with chronic hep-
atitis and cirrhosis than in healthy controls. Therefore, 
we believe that there is a somatic mosaicism in UNTS 
accompanied by hepatitis; however, telangiectasias 
may occur in response to elevated serum levels of an-
giogenic factors such as VEGF rather than estrogen. 
Although in this case we could not perform an ELISA 
test to detect serum VEGF levels due to inadequate 
laboratory conditions, we think that the hypothesis of 
VEGF relation with UNTS may shed light on the next 
studies on the UNTS etiopathogenesis.  
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Figure 2. Dilated vessels in the dermis (hematoxylin-
eosin, x40). 
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